Arkolith/Insider Trading/TLSI/Form 4

Szela Mary T

CEO AND PRESIDENT, DirectorTriSalus Life Sciences, Inc. (TLSI) · full profile →Form 4 · filed Jan 31, 2025
Net Buying
Open-Market Buys
$52K
Open-Market Sells
$0
Net Open-Market Flow
$52K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2025Buy(P)5K$5.28$26K444K
Jan 29, 2025Buy(P)5K$5.03$25K439K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-002536) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML